IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA ...Middle East

Medscape - News
Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis. MDedge News

Hence then, the article about iv secukinumab trials hit primary endpoints in psa axspa was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News